Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny heart implant aims to unclog lungs and save lives in advanced heart failure

NCT ID NCT07696975

Not yet recruiting Disease control Sponsor: V-Wave Ltd Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study tests a small, hourglass-shaped device implanted in the heart's upper chambers to lower pressure and reduce fluid buildup in the lungs. It is for people with advanced heart failure whose heart pumps weakly (ejection fraction 40% or less). The trial randomly assigns some participants to receive the shunt and others to a placebo procedure, then tracks hospitalizations and survival over several years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
V-Wave Ventura interatrial shunt
What this could lead to
If it works, this device could reduce hospitalizations and improve survival for people with advanced heart failure and reduced pumping function.
What could go wrong
This is a mid-stage trial with 250 participants. The device involves a heart procedure with risks like bleeding or infection. Previous results were mixed, so success is not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE AND REDUCED EJECTION FRACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congestive heart failure heart failure moderate heart failure systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE AND REDUCED EJECTION FRACTION HEART FAILURE CHRONIC HEART FAILURE NEW YORK HEART ASSOCIATION CLASS III HEART FAILURE, CONGESTIVE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.